This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Green Cross Corporation. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Haeng Eun Song: Innovator in Hemophilia Treatment
Introduction
Haeng Eun Song is a notable inventor based in Yongin, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hemophilia. His innovative work focuses on developing highly efficient antibody compositions that can improve patient outcomes.
Latest Patents
Haeng Eun Song holds 1 patent for a highly efficient anti-TFPI antibody composition. This patent addresses the need for effective treatments for hemophilia by providing a pharmaceutical composition that includes an anti-TFPI antibody. The composition is characterized by having a low content of HCP and LPA, which are critical for ensuring the safety and efficacy of the drug. The innovative separation and purification process he developed minimizes the generation of anti-TFPI antibody polymers, making it a promising solution for patients suffering from antibody-induced hemophilia and blood coagulation diseases.
Career Highlights
Haeng Eun Song is associated with The Green Cross Corporation, where he continues to advance his research and development efforts. His work is pivotal in creating therapies that can significantly enhance the quality of life for individuals with hemophilia.
Collaborations
He collaborates with talented coworkers such as Ji Yoon Park and Yuna Kim, contributing to a dynamic research environment that fosters innovation and excellence in pharmaceutical development.
Conclusion
Haeng Eun Song's contributions to the field of hemophilia treatment through his innovative patent demonstrate his commitment to improving patient care. His work at The Green Cross Corporation and collaborations with fellow researchers highlight the importance of teamwork in advancing medical science.